116 related articles for article (PubMed ID: 29278742)
21. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial.
Perelló MF; Coloma JL; Masoller N; Esteve J; Palacio M
BJOG; 2014 May; 121(6):706-13. PubMed ID: 24423186
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial.
Goldstein SL; Morris D; Warady BA
Am J Kidney Dis; 2013 Apr; 61(4):588-97. PubMed ID: 23245582
[TBL] [Abstract][Full Text] [Related]
23. Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.
Toblli JE; Cao G; Angerosa M
Drug Des Devel Ther; 2015; 9():2585-97. PubMed ID: 26005335
[TBL] [Abstract][Full Text] [Related]
24. Intravenous iron products.
Johnson CA; Mason NA; Bailie GR
ANNA J; 1999 Oct; 26(5):522-4. PubMed ID: 10776081
[TBL] [Abstract][Full Text] [Related]
25. Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients.
Solak Y; Atalay H; Guney I; Turkmen K; Kaya E; Turk S
Ren Fail; 2011; 33(3):307-11. PubMed ID: 21401355
[TBL] [Abstract][Full Text] [Related]
26. Targeting Iron Deficiency Anemia in Heart Failure.
Saraon T; Katz SD
Prog Cardiovasc Dis; 2016; 58(4):407-15. PubMed ID: 26657161
[TBL] [Abstract][Full Text] [Related]
27. The Use of Parenteral Iron Therapy for the Treatment of Postpartum Anemia.
Nash CM; Allen VM
J Obstet Gynaecol Can; 2015 May; 37(5):439-442. PubMed ID: 26168105
[TBL] [Abstract][Full Text] [Related]
28. Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.
Toblli JE; Di Gennaro F; Rivas C
Heart Lung Circ; 2015 Jul; 24(7):686-95. PubMed ID: 25666998
[TBL] [Abstract][Full Text] [Related]
29. Comparative rates of adverse events with different formulations of intravenous iron.
Okam MM; Mandell E; Hevelone N; Wentz R; Ross A; Abel GA
Am J Hematol; 2012 Nov; 87(11):E123-4. PubMed ID: 22965928
[TBL] [Abstract][Full Text] [Related]
30. Optimizing preoperative haemoglobin with intravenous iron.
Basora M; Colomina MJ; Tio M; Mora L; Salazar F; Ciercoles E
Br J Anaesth; 2013 Mar; 110(3):488-90. PubMed ID: 23404979
[No Abstract] [Full Text] [Related]
31. Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients.
Deira J; González-Sanchidrián S; Polanco S; Cebrián C; Jiménez M; Marín J; Gómez-Martino JR; Fernández-Pereira L; Tabernero J
Ren Fail; 2016 Aug; 38(7):1076-81. PubMed ID: 27197731
[TBL] [Abstract][Full Text] [Related]
32. Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy.
Athibovonsuk P; Manchana T; Sirisabya N
Gynecol Oncol; 2013 Dec; 131(3):679-82. PubMed ID: 24099839
[TBL] [Abstract][Full Text] [Related]
33. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial.
Froessler B; Cocchiaro C; Saadat-Gilani K; Hodyl N; Dekker G
J Matern Fetal Neonatal Med; 2013 May; 26(7):654-9. PubMed ID: 23130909
[TBL] [Abstract][Full Text] [Related]
34. Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease.
Auerbach M; Al Talib K
Kidney Int; 2008 Mar; 73(5):528-30. PubMed ID: 18274543
[TBL] [Abstract][Full Text] [Related]
35. Drug insight: Safety of intravenous iron supplementation with sodium ferric gluconate complex.
Michael B; Fishbane S; Coyne DW; Agarwal R; Warnock DG
Nat Clin Pract Nephrol; 2006 Feb; 2(2):92-100. PubMed ID: 16932400
[TBL] [Abstract][Full Text] [Related]
36. Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells.
Roth S; Langguth P; Spicher K; Enzmann H
Transl Res; 2008 Jan; 151(1):36-44. PubMed ID: 18061126
[TBL] [Abstract][Full Text] [Related]
37. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
[TBL] [Abstract][Full Text] [Related]
38. Parenteral iron sucrose in iron deficiency anaemia of paediatric chronic kidney disease.
Moorani KN; Asim S
J Ayub Med Coll Abbottabad; 2011; 23(3):47-50. PubMed ID: 23272434
[TBL] [Abstract][Full Text] [Related]
39. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
Bhavi SB; Jaju PB
BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of a single dose of intravenous ferric carboxymaltose (Ferinject) on anaemia in a pre-dialysis population of chronic kidney disease patients.
Tagboto S; Cropper L; Turner J; Pugh-Clarke K
J Ren Care; 2009 Mar; 35(1):18-23. PubMed ID: 19200274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]